Nutraceutical use in late-stage cancer

Michael J. Wargovich, Jay Morris, Vondina Brown, Jane Ellis, Britt Logothetis, Rebecca Weber

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations

Abstract

Access to a wealth of information on the internet has led many cancer patients to use complementary methods as an adjunct to traditional therapy for cancer, with, and more often, without informing their primary caregiver. Of the common complementary modalities, the use of dietary supplements appears to be highly prevalent in patients in active treatment for cancer, and later in cancer survivors. Emerging research suggests that some plant-based agents may, indeed, impact late-stage cancer, influencing molecular processes corrupted by tumor cells to evade detection, expand clonally, and invade surrounding tissues. The intent of this article is to review some of the current science underpinning the use of nutraceuticals in the latter stages of cancer.

Original languageEnglish (US)
Pages (from-to)503-510
Number of pages8
JournalCancer and Metastasis Reviews
Volume29
Issue number3
DOIs
StatePublished - Sep 2010

Keywords

  • Cancer treatment
  • Dietary supplements
  • Metastasis
  • Nutraceuticals

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Nutraceutical use in late-stage cancer'. Together they form a unique fingerprint.

Cite this